Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults
Clinical trial NCT04576702 · COMPLETED
Trial details
- NCT number
- NCT04576702
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2021-03-19
- Enrollment
- 471
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.